Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis
Open Access
- 31 October 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (10) , e0206381
Abstract
Patients with liver cirrhosis and hepatocellular carcinoma (HCC) are often ineligible for resection or local ablation therapy due to poor liver function and/or difficult location. The aim of this study is to evaluate therapeutic outcomes of stereotactic body radiotherapy (SBRT) combined with transarterial chemoembolization (TACE) compared with TACE alone for HCC measuring less than 5 cm. From March 2011 to December 2016, 85 patients underwent SBRT with TACE (SBRT-TACE group) and 114 underwent TACE (TACE group) at 4 tertiary hospitals. Local control rate (LCR), progression-free survival (PFS) and overall survival (OS) were compared after propensity-score matching (1:1 ratio). The SBRT-TACE group showed significantly higher 1- and 3-year LCR than the TACE group (91.1% and 89.9%, respectively vs 69.9% and 44.8%, respectively; P < 0.001). The SBRT-TACE group showed better 1- and 3-year PFS than the TACE group (56.5% and 32.3%, respectively vs 42.2% and 21.6%, respectively; P = 0.022). However, 1-, 3- and 5-year OS was not different between the SBRT-TACE and TACE groups (98.8%, 89.1% and 80.7%, respectively vs 99.7%, 83.3% and 71.0%, respectively; P = 0.206). In multivariate analysis, the overall SBRT added to TACE did not contribute to extend PFS. However, in patients with less than 2 tumors, the combined therapy was effective (HR 0.590, 95% CI 0.392–0.889, P = 0.012). SBRT-TACE is superior to TACE in terms of LCR. Particularly, SBRT-TACE may be an effective alternative in patients with HCC number (≤2), which is not indicated for resection or local ablation.Keywords
This publication has 32 references indexed in Scilit:
- Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular CarcinomaPLOS ONE, 2013
- Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patientsActa Oncologica, 2013
- Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Report of the 18th follow‐up survey of primary liver cancer in JapanHepatology Research, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Radiation-Associated Liver InjuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Transcatheter Arterial Embolization with Only Particles for the Treatment of Unresectable Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2008
- Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation toleranceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Hepatic toxicity resulting from cancer treatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995